Search Results - "Zarour HM"

Immunotherapy innovations in triple-negative breast cancer: targeting checkpoints, combinations, and biomarkers.

Authors: Wang, Zi-Xin Chu, Ju-Hang Wang, Ya-Ru et al.

Source: Oncology Reviews. 2026, p1-12. 12p.

TIGIT blockade improves anti-Mycobacterium tuberculosis immunity.

Authors: Zhou, Jingyu Yang, Qingluan Xu, Haoxin et al.

Source: PLoS Pathogens. 6/17/2025, Vol. 21 Issue 6, p1-19. 19p.

Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy.

Authors: Phelps CM Willis NB Duan T et al.

Source: Cell [Cell] 2025 Oct 02; Vol. 188 (20), pp. 5680-5700.e28. Date of Electronic Publication: 2025 Jul 09.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Endometrial expression of T-cell immunoreceptor with Ig and ITIM domains and cluster of differentiation 155: A case-control study of a novel immunomodulatory axis in endometriosis.

Authors: Nematollahi, Reyhane Samadi, Morteza Montazeri, Fateme et al.

Source: International Journal of Reproductive Biomedicine. 2026, Vol. 24 Issue 3, p257-264. 8p.

Development and characterisation of [¹⁸F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates.

Authors: Wang, Jing Hu, Xinxin Wang, Yueqi et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2025, Vol. 52 Issue 2, p416-426. 11p.

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.

Authors: Shaikh SS Zang Y Hanmer J et al.

Source: Frontiers in oncology [Front Oncol] 2022 Nov 23; Vol. 12, pp. 1022496. Date of Electronic Publication: 2022 Nov 23 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Targeting LAG3 to alter the tumor immune reactivity of CD8+T cells is a potential therapy for skin cutaneous melanoma.

Authors: Gong, Jin Zhao, Yan Gong, Shaozhi et al.

Source: Scientific Reports. 10/29/2025, Vol. 15 Issue 1, p1-12. 12p.

The effect of immunomodulatory celecoxsib on the gene expression of inhibitory receptors in dendritic cells generated from monocyte cells.

Authors: Hashemi, Vida Baradaran, Behzad Naseri, Bahar et al.

Source: BMC Research Notes. 4/13/2025, Vol. 18 Issue 1, p1-7. 7p.

Clinical and immunological implications of lymphocyte-activation gene 3 expression in metastatic colorectal cancer.

Authors: Huang YH Wu SY Lee CT et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 03; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Multomic analysis reveals the potential of LAG3 as a prognostic and immune biomarker and its validation in osteosarcoma.

Authors: Cao, Qianqian Zhang, Yuzhe Cheng, Cheng et al.

Source: Scientific Reports. 7/11/2025, Vol. 15 Issue 1, p1-24. 24p.

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.

Authors: Tompkins AG Gray ZN Dadey RE et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 12; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 12.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

VSIG4 Promotes Tumour‐Associated Macrophage M2 Polarization and Immune Escape in Colorectal Cancer via Fatty Acid Oxidation Pathway.

Authors: Liu, Jiafeng Zhang, WenXin Chen, Lu et al.

Source: Clinical & Translational Medicine. May2025, Vol. 15 Issue 5, p1-23. 23p.

Staining pattern of specific and cross‐reacting Melan‐A antibodies: A comparative study on 15,840 samples from 133 human tumor types.

Authors: Boroojerdi, Shiva Weidemann, Sören Menz, Anne et al.

Source: APMIS. Jul2024, Vol. 132 Issue 7, p479-491. 13p.

T‐cell exhaustion from a multiomics perspective: Differentiation mechanisms and regulatory networks in the journey from progenitor‐Exhausted T cells to terminally exhausted T cells.

Authors: Zhu, Tong Teng, Xiaoyu Jiao, Qinlian et al.

Source: Clinical & Translational Medicine. Feb2026, Vol. 16 Issue 2, p1-25. 25p.

Vaccins thérapeutiques anticancer : l'exemple du mélanome.

Authors: Suleiman, Lutfi Gocko, Xavier

Source: Médecine. feb2026, Vol. 22 Issue 2, p60-66. 7p.

Lactobacillus gasseri LGV03-derived indole-3-lactic acid ameliorates immune response by activating aryl hydrocarbon receptor.

Authors: Zhang, Zikang Zheng, Kangdi Zhang, Zhao et al.

Source: Microbial Cell Factories. 1/30/2025, Vol. 24 Issue 1, p1-14. 14p.

Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.

Authors: Bastacky ML Wang H Fortman D et al.

Source: Frontiers in oncology [Front Oncol] 2021 Nov 26; Vol. 11, pp. 749064. Date of Electronic Publication: 2021 Nov 26 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns.

Authors: Quatannens D Verhoeven Y van der Heijden S et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 10; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures.

Authors: Petouhoff A Hicks R Husain M et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 09; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 09.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Gut microbiota and cancer immunotherapy: from dysbiosis to personalized immune checkpoint blockade optimization.

Authors: Akram F Zainab S Shabbir I et al.

Source: Folia microbiologica [Folia Microbiol (Praha)] 2026 May 27. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 0376757 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1874-9356 (Electronic) Linking ISSN: 00155632 NLM ISO Abbreviation: Folia Microbiol (Praha) Subsets: MEDLINE